Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

APhA consumer Web site

This article was originally published in The Tan Sheet

Executive Summary

Focuses on the role pharmacists can play in helping consumers choose OTC medicines. "Your pharmacist can advise you about selecting nonprescription ('over-the-counter') medications and products for your family," the site tells consumers under the heading "Your Household's Medication Inventory." Pharmacists "can provide you with valuable information when treating minor ailments or mishaps at home," it adds. The site also includes topics such as "Ask your Pharmacist about Nonprescription Medicines"; "Guide to Educating Children About Medicines"; "Making Your Medications Work Better"; "Understanding Your Medicines" and "Avoiding Medication Errors." The section dedicated to OTCs says if consumers are "still not sure which medicine to take after reading the label" it is "time to ask your pharmacist for help"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel